Andera Partners logo

Andera Partners

Europe, Ile-de-France, France, Paris

Description

Andera Partners is a private equity firm focused on early- and late-stage venture investments.

Investor Profile

Andera Partners has made 204 investments, with 10 in the past 12 months and 38% as lead.

Stage Focus

  • Series B (23%)
  • Series Unknown (21%)
  • Private Equity (19%)
  • Series A (15%)
  • Series C (14%)
  • Series D (4%)
  • Post Ipo Equity (3%)
  • Seed (1%)

Country Focus

  • France (50%)
  • United States (17%)
  • Germany (8%)
  • Switzerland (6%)
  • United Kingdom (6%)
  • Belgium (3%)
  • Italy (3%)
  • Ireland (2%)
  • Spain (2%)
  • The Netherlands (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Medical Device
  • Pharmaceutical
  • Biopharma
  • Manufacturing
  • Information Technology
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Andera Partners frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 11
OrbiMed
North America, New York, United States, New York
Co-Investments: 10
Gimv
Europe, Antwerpen, Belgium, Antwerpen
Co-Investments: 13
Omnes Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 10
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 10
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 13
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 18
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 15
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 19
Auriga Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 13

Which angels does Andera Partners often collaborate with?

NB
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1
JC
Europe, Surrey, United Kingdom, Weybridge
Shared Deals: 1
EC
Europe, Ile-de-France, France, Paris
Shared Deals: 1

What are some of recent deals done by Andera Partners?

EG 427

Paris, Ile-de-France, France

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

BiotechnologyGeneticsTherapeutics
Series BFeb 20, 2025
Amount Raised: $28,166,046
Bioptimus

Paris, Ile-de-France, France

Bioptimus is an AI company that offers a foundation model for biology to fuel breakthrough discoveries and accelerate.

Artificial Intelligence (AI)BiotechnologyGenerative AI
Series AJan 14, 2025
Amount Raised: $41,000,000
FIRE1

Dublin, Dublin, Ireland

FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series UnknownJan 7, 2025
Amount Raised: $120,000,000
Evommune

Palo Alto, California, United States

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

BiotechnologyHealth CareLife Science
Series COct 31, 2024
Amount Raised: $115,000,000
Inventiva Pharma

Daix, Bourgogne, France

Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

BiopharmaBiotechnologyClinical TrialsMedicalMedical Device
Post Ipo EquityOct 14, 2024
Amount Raised: $126,004,765
Qovoltis

Arcueil, Ile-de-France, France

Qovoltis offers smart charging solutions for electric vehicles and a mobile app for remote management.

Electric VehicleMobile AppsSoftware
Series BOct 3, 2024
Amount Raised: $49,658,953
Skysun

Genappe, Brabant Wallon, Belgium

Skysun is a financial institution that provides financial solutions and services to the solar energy sector.

EnergyFinanceFinancial ServicesSolar
Series ASep 10, 2024
Amount Raised: $18,734,558
Kestra Medical Technologies, Inc.

Kirkland, Washington, United States

Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.

Health CareHealth DiagnosticsMedical Device
Private EquityJul 24, 2024
Amount Raised: $196,000,000
SciRhom

Martinsried, Bayern, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

BiotechnologyHealth Care
Series AJul 9, 2024
Amount Raised: $68,190,674
Grey Wolf Therapeutics

Abingdon, Oxfordshire, United Kingdom

First-of-its-kind antigen modulation to address immune dysfunction in oncology and autoimmunity

BiotechnologyHealth CareTherapeutics
Series BMay 23, 2024
Amount Raised: $50,000,000